KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-α production (Q73635302)
scientific article published on 01 January 1997
Language:
(P31) (Q13442814)
(P304) 795-803
(P407) (Q1860)
(P433) 8
(P478) 61
(P577) Wednesday, January 1, 1997
Wednesday, January 1, 1997
(P953) https://api.elsevier.com/content/article/PII:S0024320597005614?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0024320597005614?httpAccept=text/plain
(P1433) (Q5256275)
(P1476) "KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-alpha production" (language: en)
"KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-α production" (language: en)
(P2093) Y. Morimoto
K. Nishikawa
M. Ohashi
(P2860) (Q42467904)
(Q51603092)
(Q28131660)
(Q54217923)
(Q29012156)
(Q37352139)
(Q34190131)
(Q59059630)
(Q41447978)
(Q41454044)
(Q38296976)
(Q54287151)
(Q41450210)
(Q72867542)
(Q41507936)
(Q38287981)
(Q29615221)
(Q68094187)
(Q67804825)
(Q2160146)
other details
description scientific article published on 01 January 1997

External Links